Interestingly, Lal et al. (2022) indicated metformin as a top repurposed drug candidate for AF, discussing the proximity of NPPB (brain natriuretic peptide) and CXCL12 to the metformin target DPP4. This evidence concerns the gene CXCL12 and atrial fibrillation.